AUTHOR=Fisher Naomi D. L. , Almeida Tiago P. , Perruchoud David , Shah Jay , Sola Josep TITLE=Optimizing time-in-target-range assessment for blood pressure: insights from a large-scale study with continual cuffless monitoring JOURNAL=Frontiers in Medicine VOLUME=11 YEAR=2024 URL=https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2024.1396962 DOI=10.3389/fmed.2024.1396962 ISSN=2296-858X ABSTRACT=Introduction

Blood pressure (BP) time-in-target-range (TTR) is an emerging predictor of cardiovascular risk. Conventional BP methods are fundamentally unable to provide an optimal assessment of TTR, using irregular measurements separated by lengthy intervals. We investigated the optimal duration and frequency for reliable, practical TTR assessment in clinical settings using continual monitoring.

Methods

This retrospective study analyzed 2.3 million BP readings from 5,189 European home users (55 ± 11 years, 82% male, BMI 28.0 ± 5.8) using a cuffless BP monitor (Aktiia SA). Systolic BP (SBP) data over 15 consecutive days were assessed (29 ± 11 readings/subject/24-h; 434 + 132 readings/subject/15-day). Subjects were classified into risk-related TTR groups based on 15-day SBP data (24-h, target 90–125 mmHg; ≥6 daytime readings). Various measurement frequencies and durations (1–14 days; 24-h/daytime; 2, 4 or ≥ 6 readings/day) were compared to this reference. Two specific configurations paralleling ambulatory (“One-Day-24 h”) and home (“One-Week-Daytime”) BP monitoring were selected for detailed analysis.

Results

The reference TTR classified 63.0% of the subjects as high risk, 19.0% intermediate, and 18.0% low. “One-Day-24 h” schedule inaccurately classified 26% of subjects compared to the reference TTR, and “One-Week-Daytime” schedule inaccurately classified 45%. Classification accuracy with both schedules was high for subjects with very low or very high reference TTR, but poor otherwise. Accuracy of ≥90% in TTR classification only occurred with 7 days of continual 24-h monitoring.

Discussion

For the first time, with the benefit of a cuffless device that measures BP with sufficient frequency and duration, practical use of TTR is enabled as a potentially enhanced metric to manage hypertension.